@misc{indiciae9571e1776016,
  title = {Drug-gene interaction screens coupled to tumour data analyses identify the most clinically-relevant cancer vulnerabilities driving sensitivity to PARP inhibition},
  author = {Jamal, K. and Galbiati, A. and Armenia, J. and Illuzzi, G. and Hall, J. and Bentouati, S. and Barrell, D. and Ahdesmäki, M. and Functional Genomics Centre, and O'Connor, M. J. and Leo, E. and Forment, J. V.},
  year = {2022},
  doi = {10.1101/2022.07.29.501846},
  url = {https://www.biorxiv.org/content/10.1101/2022.07.29.501846v1},
  note = {Source identifier: 10.1101/2022.07.29.501846}
}